Naftifine

DEA Class; Rx

Common Brand Names; Naftin

• Antifungals, Topical

Topical allylamine antifungal
Indicated for the interdigital tinea pedis, tinea cruris, and tinea corporis
Similar efficacy and adverse events profiles to topical azole antifungals

Hypersensitivity

Transient burning/stinging (5-6%)

Skin tenderness (0.5-3%)

Dryness

Erythema

Pruritus

Local irritation

Rash

Avoid use of occlusive dressings or wrappings

Keep the cream away from eyes, nose, mouth, & other mucous membranes

Reevaluate dx if no improvement after 4 wk

Discontinue treatment if irritation or sensitivity develops with use; direct patients to contact their physician if these conditions develop

Pregnancy: There are no available data in pregnant women to inform the drug-associated risk for major birth defects and miscarriage

Lactation: There is no information available on presence of drug in human milk, effects of drug on breastfed infant, or effects of drug on milk production

Naftifine hydrochloride

topical cream

• 1%
• 2%

topical gel

• 1%
• 2%